ParvezMantryMDAGAF, FAASLD

Clinical Trials

• Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease Start of enrollment: 2005 Jun 01

  Withdrawn

  Phase 1, Phase 2

• Autoimmune Hepatitis Study Start of enrollment: 2006 Jan 01

  Terminated

• Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01

  Completed

  Phase 3

• Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03

  Terminated

  Phase 4

• Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection Start of enrollment: 2013 Jun 01

  Unknown status

  Phase 2

• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22

  Terminated

  Phase 3

• Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 Start of enrollment: 2016 Jul 31

  Withdrawn

  Early Phase 1

• TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer Start of enrollment: 2014 May 22

  Completed

  Not Applicable

• Mindfulness and Shared Decision Making Start of enrollment: 2018 Aug 15

  Completed

• CM-101 in PSC Patients -The SPRING Study Start of enrollment: 2020 Oct 01

  Active, not recruiting

  Phase 2

  Roles: Contact

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement Start of enrollment: 2023 May 12

  Recruiting

  Phase 2

  Roles: Principal Investigator

• Join now to see all